Nutritional quality of food as represented by the FSAm-NPS nutrient profiling system underlying the Nutri-Score label and cancer risk in Europe: Results from the EPIC prospective cohort study
Publication date
2018-09-01
Authors
Deschasaux, Mélanie
Huybrechts, Inge
Murphy, Neil
Julia, Chantal
Hercberg, Serge
Srour, Bernard
Kesse-Guyot, Emmanuelle
Latino-Martel, Paule
Biessy, Carine
Casagrande, Corinne
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
No license information available
Abstract
Background: Helping consumers make healthier food choices is a key issue for the prevention of cancer and other diseases. In many countries, political authorities are considering the implementation of a simplified labelling system to reflect the nutritional quality of food products. The Nutri-Score, a five-colour nutrition label, is derived from the Nutrient Profiling System of the British Food Standards Agency (modified version) (FSAm-NPS). How the consumption of foods with high/low FSAm-NPS relates to cancer risk has been studied in national/regional cohorts but has not been characterized in diverse European populations. Methods and findings: This prospective analysis included 471,495 adults from the European Prospective Investigation into Cancer and Nutrition (EPIC, 1992–2014, median follow-up: 15.3 y), among whom there were 49,794 incident cancer cases (main locations: breast, n = 12,063; prostate, n = 6,745; colon-rectum, n = 5,806). Usual food intakes were assessed with standardized country-specific diet assessment methods. The FSAm-NPS was calculated for each food/beverage using their 100-g content in energy, sugar, saturated fatty acid, sodium, fibres, proteins, and fruits/vegetables/legumes/nuts. The FSAm-NPS scores of all food items usually consumed by a participant were averaged to obtain the individual FSAm-NPS Dietary Index (DI) scores. Multi-adjusted Cox proportional hazards models were computed. A higher FSAm-NPS DI score, reflecting a lower nutritional quality of the food consumed, was associated with a higher risk of total cancer (HRQ5 versus Q1 = 1.07; 95% CI 1.03–1.10, P-trend < 0.001). Absolute cancer rates in those with high and low (quintiles 5 and 1) FSAm-NPS DI scores were 81.4 and 69.5 cases/10,000 person-years, respectively. Higher FSAm-NPS DI scores were specifically associated with higher risks of cancers of the colon-rectum, upper aerodigestive tract and stomach, lung for men, and liver and postmenopausal breast for women (all P < 0.05). The main study limitation is that it was based on an observational cohort using self-reported dietary data obtained through a single baseline food frequency questionnaire; thus, exposure misclassification and residual confounding cannot be ruled out. Conclusions: In this large multinational European cohort, the consumption of food products with a higher FSAm-NPS score (lower nutritional quality) was associated with a higher risk of cancer. This supports the relevance of the FSAm-NPS as underlying nutrient profiling system for front-of-pack nutrition labels, as well as for other public health nutritional measures.
Keywords
General Medicine
Citation
Deschasaux, M, Huybrechts, I, Murphy, N, Julia, C, Hercberg, S, Srour, B, Kesse-Guyot, E, Latino-Martel, P, Biessy, C, Casagrande, C, Jenab, M, Ward, H, Weiderpass, E, Dahm, C C, Overvad, K, Kyrø, C, Olsen, A, Affret, A, Boutron-Ruault, M C, Mahamat-Saleh, Y, Kaaks, R, Kühn, T, Boeing, H, Schwingshackl, L, Bamia, C, Peppa, E, Trichopoulou, A, Masala, G, Krogh, V, Panico, S, Tumino, R, Sacerdote, C, Bueno-de-Mesquita, B, Peeters, P H, Hjartåker, A, Rylander, C, Skeie, G, Ramón Quirós, J, Jakszyn, P, Salamanca-Fernández, E, Huerta, J M, Ardanaz, E, Amiano, P, Ericson, U, Sonestedt, E, Huseinovic, E, Johansson, I, Khaw, K T, Wareham, N, Bradbury, K E, Perez-Cornago, A, Tsilidis, K K, Ferrari, P, Riboli, E, Gunter, M J & Touvier, M 2018, 'Nutritional quality of food as represented by the FSAm-NPS nutrient profiling system underlying the Nutri-Score label and cancer risk in Europe : Results from the EPIC prospective cohort study', PLoS Medicine, vol. 15, no. 9, e1002651. https://doi.org/10.1371/journal.pmed.1002651